Skip to content

Kailera Therapeutics

US · KLRA #3073 by market cap Listed 2026
10.53 -0.30 -2.77%
Live - 5344 symbols - heartbeat 510s ago · 2026-10-08 07:08
Pre-market 10.68 +1.42%
After-hours 10.53 0.00%
Market cap
1.37B
P/B
1.22
EPS
-0.01
Reader sentiment Are you bullish or bearish on KLRA?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 4 analysts

Buy
Avg price target 45.00 +327.4%
Price target rangecurrent 10.53
Low30.00
Avg45.00
High57.00
Buy 100% Hold 0% Sell 0%
Recent ratings (19)
DateFirmAnalystRatingTarget
2026-09-30 William Blair -- BUY --
2026-09-29 TD Cowen -- BUY 57.00
2026-08-14 Jefferies -- BUY 48.00
2026-08-13 TD Cowen -- BUY 57.00
2026-08-12 William Blair -- BUY --
2026-08-12 J.P. Morgan -- BUY 30.00
2026-07-08 Jefferies -- BUY 48.00
2026-07-07 TD Cowen -- BUY 57.00
2026-07-07 William Blair -- BUY --
2026-05-28 Jefferies -- BUY 48.00
2026-05-27 William Blair -- BUY --
2026-05-26 TD Cowen -- BUY --
2026-05-21 TD Cowen -- BUY 57.00
2026-05-16 William Blair -- BUY --
2026-05-12 TD Cowen -- BUY 57.00
2026-05-12 William Blair -- BUY --
2026-05-12 Jefferies -- BUY 48.00
2026-05-12 Evercore -- BUY --
2026-05-12 J.P. Morgan -- BUY 30.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

Quote time 2026-10-08 07:08:07 · For reference only, not investment advice and not tailored to your situation.